Efficacy and safety of a combined treatment of sodium stibogluconate at 20mg/kg/day with upper maximum daily dose limit of 850mg and Paromomycin 15mg/kg/day in HIV negative visceral leishmaniasis patients. A retrospective study, northwest Ethiopia.

• Hlavní autoři: Aschalew Tamiru (Autor), Rezika Mohammed (Autor), Saba Atnafu (Autor), Girmay Medhin (Autor), Asrat Hailu (Autor)
• Médium: Kniha
• Vydáno: Public Library of Science (PLoS), 2021-08-01T00:00:00Z.
• Témata: article
• On-line přístup: Connect to this object online.

<h4>Background</h4>Visceral leishmaniasis (VL) is one of the most neglected tropical infectious diseases. It is fatal if left untreated. The objective of this study was to assess the efficacy and safety of 17-day injections of combined regimen of sodium stibogluconate and paromomycin (SS...